A panel discussion with experts in medication and patient safety, which links current and future activity to the WHO Global Patient Safety Challenge “Medication Without Harm”. A short introduction by each panellist will be followed by an interactive question and answer session which will highlight a range of perspectives to this particularly topical issue

Anticoagulation saves live - that’s not in doubt. But how confident are you in choosing the right drug for the right patient, given the number of agents, the variety of patients, and all of their comorbidities and concomitant medications? Ms Satinder Bhandal and Dr James Uprichard share their respective pharmacy and clinician expertise in a case-based guide to determining the appropriate DOAC.

Present guidance from key national publications to highlight what clinical pharmacy services fit for an ageing population should look like. Use service data and real patient scenarios to demonstrate how the GSTT Pharmacy integrated care model is transforming medicines services for frail older people through active collaboration with health and social care multidisciplinary teams. Challenge delegates to look beyond one-off, silo pharmacy initiatives for tackling polypharmacy to developing sustainable services aligned across local economies where patients have ready access to a pharmacist with the right clinical skills and expertise

Psoriasis is a chronic, relapsing-remitting, inflammatory skin condition affecting up to 3% of the population in the UK. This presentation provides an overview of psoriasis and its management and discusses recent treatment advances in biologics and how these may be adopted in local treatment pathways.

The NHS Improvement Model Hospital (including the Top 10 medicines) has been a significant driver for change. Building on the HoPMOp foundations the future collaboration between and development of hospital pharmacy services will continue to support patient care with medicines

The Medicines Data Programme in NHS Digital will take a partnership approach to deliver a transformation in medicines data for secondary uses. This presentation will explain what has already been done and what the next steps are in providing comprehensive data and intelligence on the, use, spend, effectiveness and safety of medicines.

A review of an aseptic compounding software installation in the NHS.
Following Jeremy Hunt’s reference to 237 million medication errors per year and Lord Carter reports, Faye and Louisa from the Birmingham University Hospital, provide a clinical understanding of the safety and efficiency outcomes in an oncology setting. This talk will consider leading innovation to support clinical staff in reducing medication errors during IV manufacturing and steps to improve patient safety before reaching bedside administration.

IQVIA™ has unique access to dispensing data across the UK in both Primary and Secondary Care with 100% of NHS Acute Trust dispensing data. This is available to reflect insight back to the NHS. In the session we will look at the data and how it is used in more detail and demonstrate the insights gained from a clinical pharmacy perspective.

The medicines strategic framework covers the use of medicines for people with mental health problems and those with a learning disability across the age range from children to older people. It focuses on psychotropic medicines, but also recognises the importance of oral/physical health in people with mental health problems/ learning disability and their care and treatment within the wider health and social care environments.

Presenting an update on the latest projects being developed by NHS Digital. To enable pharmacists to be ‘fit for the future’ working across different care settings, effectively and efficiently. This presentation details how we are providing the digital capability to enable pharmacy to share and receive patient information more effectively within the NHS enabling high quality patient care.

An essential presentation, from a GP perspective, for those who want to fully understand how to seamlessly embed the practice pharmacist as part of the general practice MDT. Hear from a GP about what matters to them most and how practice pharmacists provide an irrefutable return on investment.

Organised by

Quick links

Information was correct at time of press. CloserStill reserve the right to amend content without prior warning. The conference has been brought to you by CloserStill Media in association with our partners and sponsors. The views and opinions of the speakers are not necessarily those of CloserStill Media or of our partners and sponsors. Sponsors have not had any input into the programme except where an individual session states it’s sponsored. The session topic and speaker have been developed by each sponsoring company.